219 related articles for article (PubMed ID: 11170080)
1. Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG.
Yoshida H; Horie M; Otani H; Kawashima T; Onishi Y; Sasayama S
Am J Med Genet; 2001 Feb; 98(4):348-52. PubMed ID: 11170080
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel missense mutation in the pore of HERG in a patient with long QT syndrome.
Yoshida H; Horie M; Otani H; Takano M; Tsuji K; Kubota T; Fukunami M; Sasayama S
J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1262-70. PubMed ID: 10517660
[TBL] [Abstract][Full Text] [Related]
3. Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG.
Hayashi K; Shimizu M; Ino H; Yamaguchi M; Terai H; Hoshi N; Higashida H; Terashima N; Uno Y; Kanaya H; Mabuchi H
Clin Sci (Lond); 2004 Aug; 107(2):175-82. PubMed ID: 15043509
[TBL] [Abstract][Full Text] [Related]
4. The distinct HERG missense mutation L564P causes long QT syndrome in one French Canadian family.
St-Pierre J; Roy N; Blier L; Plante E; Cote JM; Gilbert M; Chahine M
Can J Cardiol; 2000 Mar; 16(3):307-12. PubMed ID: 10744792
[TBL] [Abstract][Full Text] [Related]
5. Novel missense mutation (G601S) of HERG in a Japanese long QT syndrome family.
Akimoto K; Furutani M; Imamura S; Furutani Y; Kasanuki H; Takao A; Momma K; Matsuoka R
Hum Mutat; 1998; Suppl 1():S184-6. PubMed ID: 9452080
[No Abstract] [Full Text] [Related]
6. Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome.
Johnson WH; Yang P; Yang T; Lau YR; Mostella BA; Wolff DJ; Roden DM; Benson DW
Pediatr Res; 2003 May; 53(5):744-8. PubMed ID: 12621127
[TBL] [Abstract][Full Text] [Related]
7. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
[TBL] [Abstract][Full Text] [Related]
8. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.
Hayashi K; Shimizu M; Ino H; Yamaguchi M; Mabuchi H; Hoshi N; Higashida H
Cardiovasc Res; 2002 Apr; 54(1):67-76. PubMed ID: 12062363
[TBL] [Abstract][Full Text] [Related]
10. C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence.
Berthet M; Denjoy I; Donger C; Demay L; Hammoude H; Klug D; Schulze-Bahr E; Richard P; Funke H; Schwartz K; Coumel P; Hainque B; Guicheney P
Circulation; 1999 Mar; 99(11):1464-70. PubMed ID: 10086971
[TBL] [Abstract][Full Text] [Related]
11. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns.
Piippo K; Laitinen P; Swan H; Toivonen L; Viitasalo M; Pasternack M; Paavonen K; Chapman H; Wann KT; Hirvelä E; Sajantila A; Kontula K
J Am Coll Cardiol; 2000 Jun; 35(7):1919-25. PubMed ID: 10841244
[TBL] [Abstract][Full Text] [Related]
12. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
Vincent GM
Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation.
Nakajima T; Furukawa T; Tanaka T; Katayama Y; Nagai R; Nakamura Y; Hiraoka M
Circ Res; 1998 Aug; 83(4):415-22. PubMed ID: 9721698
[TBL] [Abstract][Full Text] [Related]
14. Identical twins with long QT syndrome associated with a missense mutation in the S4 region of the HERG.
Hayashi K; Shimizu M; Ino H; Okeie K; Yamaguchi M; Yasuda T; Fujino N; Fujii H; Fujita S; Mabuchi H
Jpn Heart J; 2000 May; 41(3):399-404. PubMed ID: 10987356
[TBL] [Abstract][Full Text] [Related]
15. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.
Nakajima T; Furukawa T; Hirano Y; Tanaka T; Sakurada H; Takahashi T; Nagai R; Itoh T; Katayama Y; Nakamura Y; Hiraoka M
Cardiovasc Res; 1999 Nov; 44(2):283-93. PubMed ID: 10690305
[TBL] [Abstract][Full Text] [Related]
16. QT interval prolongation and cardiac risk assessment for novel drugs.
Picard S; Lacroix P
Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
[TBL] [Abstract][Full Text] [Related]
17. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.
Ficker E; Thomas D; Viswanathan PC; Dennis AT; Priori SG; Napolitano C; Memmi M; Wible BA; Kaufman ES; Iyengar S; Schwartz PJ; Rudy Y; Brown AM
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1748-56. PubMed ID: 11009462
[TBL] [Abstract][Full Text] [Related]
18. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates.
Chevalier P; Rodriguez C; Bontemps L; Miquel M; Kirkorian G; Rousson R; Potet F; Schott JJ; Baró I; Touboul P
Cardiovasc Res; 2001 May; 50(2):386-98. PubMed ID: 11334843
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.
Isbrandt D; Friederich P; Solth A; Haverkamp W; Ebneth A; Borggrefe M; Funke H; Sauter K; Breithardt G; Pongs O; Schulze-Bahr E
J Mol Med (Berl); 2002 Aug; 80(8):524-32. PubMed ID: 12185453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
